GlcCer (d18:1/18:0), CAS [[95119-86-1]]

Produktübersicht

• Artikelname: GlcCer (d18:1/18:0), CAS [[95119-86-1]]
• Artikelnummer: MCE-HY-170035
• Hersteller Artikelnummer: HY-170035
• Alternativnummer: MCE-HY-170035-5MG,MCE-HY-170035-1MG,MCE-HY-170035-10MG,MCE-HY-170035-25MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: C18 Glucosyl(beta) ceramide (d18:1/18:0), D-glucosyl-beta-1,1 N-stearoyl-D-erythro-sphingosine

Produktbeschreibung

GlcCer (d18:1/18:0) (C18 Glucosyl(beta) ceramide (d18:1/18:0)) is a glycosphingolipids that activates the Wnt/beta-catenin pathway by targeting LRP6. GlcCer (d18:1/18:0) drives EMT, migration, invasion and GBA1-mediated liver cancer metastasis. GlcCer (d18:1/18:0) accumulates to impair lysosomal function and induce toxic alpha-synuclein aggregation. GlcCer (d18:1/18:0) supports growth, sporulation, germination and virulence in Penicillium digitatum. GlcCer (d18:1/18:0) is reduced in demyelinated mouse corpus callosum. GlcCer (d18:1/18:0) can be used for the research of liver cancer, synucleinopathies, fungal, Parkinsons disease and Gaucher disease[1][2][3][4][5].

Produkteigenschaften

• Molekulargewicht: 728.09
• Reinheit: 99.93
• CAS Nummer: [95119-86-1]
• Formel: C42H81NO8
• Target-Kategorie: Fungal,Wnt,beta-catenin

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Natural Products